Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 209

1.

The effect of genistein aglycone on cancer and cancer risk: a review of in vitro, preclinical, and clinical studies.

Taylor CK, Levy RM, Elliott JC, Burnett BP.

Nutr Rev. 2009 Jul;67(7):398-415. doi: 10.1111/j.1753-4887.2009.00213.x. Review.

PMID:
19566600
2.

Soy for breast cancer survivors: a critical review of the literature.

Messina MJ, Loprinzi CL.

J Nutr. 2001 Nov;131(11 Suppl):3095S-108S. Review.

3.

Addressing the soy and breast cancer relationship: review, commentary, and workshop proceedings.

Messina M, McCaskill-Stevens W, Lampe JW.

J Natl Cancer Inst. 2006 Sep 20;98(18):1275-84. Review.

PMID:
16985246
4.

Anticarcinogenic effects of isoflavones may be mediated by genistein in mouse mammary tumor virus-induced breast cancer.

Mizunuma H, Kanazawa K, Ogura S, Otsuka S, Nagai H.

Oncology. 2002;62(1):78-84.

PMID:
11810047
5.

Perspectives on the soy-breast cancer relation.

Messina M, Wu AH.

Am J Clin Nutr. 2009 May;89(5):1673S-1679S. doi: 10.3945/ajcn.2009.26736V. Epub 2009 Apr 1.

6.

Meta-analysis of soy intake and breast cancer risk.

Trock BJ, Hilakivi-Clarke L, Clarke R.

J Natl Cancer Inst. 2006 Apr 5;98(7):459-71.

PMID:
16595782
7.

Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast.

McMichael-Phillips DF, Harding C, Morton M, Roberts SA, Howell A, Potten CS, Bundred NJ.

Am J Clin Nutr. 1998 Dec;68(6 Suppl):1431S-1435S.

PMID:
9848512
8.

Critical review of health effects of soyabean phyto-oestrogens in post-menopausal women.

Cassidy A, Albertazzi P, Lise Nielsen I, Hall W, Williamson G, Tetens I, Atkins S, Cross H, Manios Y, Wolk A, Steiner C, Branca F.

Proc Nutr Soc. 2006 Feb;65(1):76-92. Review.

PMID:
16441947
9.

Soyfoods, isoflavones and risk of colonic cancer: a review of the in vitro and in vivo data.

Messina M, Bennink M.

Baillieres Clin Endocrinol Metab. 1998 Dec;12(4):707-28. Review.

PMID:
10384821
10.

Early intake appears to be the key to the proposed protective effects of soy intake against breast cancer.

Messina M, Hilakivi-Clarke L.

Nutr Cancer. 2009;61(6):792-8. doi: 10.1080/01635580903285015.

PMID:
20155618
11.

Plasma isoflavone level and subsequent risk of breast cancer among Japanese women: a nested case-control study from the Japan Public Health Center-based prospective study group.

Iwasaki M, Inoue M, Otani T, Sasazuki S, Kurahashi N, Miura T, Yamamoto S, Tsugane S; Japan Public Health Center-based prospective study group.

J Clin Oncol. 2008 Apr 1;26(10):1677-83. doi: 10.1200/JCO.2007.13.9964. Epub 2008 Mar 3.

PMID:
18316793
13.

Soy isoflavones and cancer prevention.

Sarkar FH, Li Y.

Cancer Invest. 2003;21(5):744-57. Review.

PMID:
14628433
14.

Soy intake and cancer risk: a review of the in vitro and in vivo data.

Messina MJ, Persky V, Setchell KD, Barnes S.

Nutr Cancer. 1994;21(2):113-31. Review.

PMID:
8058523
15.
16.

Genistein aglycone: a dual mode of action anti-osteoporotic soy isoflavone rebalancing bone turnover towards bone formation.

Bitto A, Polito F, Squadrito F, Marini H, D'Anna R, Irrera N, Minutoli L, Granese R, Altavilla D.

Curr Med Chem. 2010;17(27):3007-18. Review.

PMID:
20629630
17.

Cytostatic and cytotoxic activity of synthetic genistein glycosides against human cancer cell lines.

Polkowski K, Popiołkiewicz J, Krzeczyński P, Ramza J, Pucko W, Zegrocka-Stendel O, Boryski J, Skierski JS, Mazurek AP, Grynkiewicz G.

Cancer Lett. 2004 Jan 8;203(1):59-69.

PMID:
14670618
18.

Soy isoflavones increase latency of spontaneous mammary tumors in mice.

Jin Z, MacDonald RS.

J Nutr. 2002 Oct;132(10):3186-90.

19.

The role of soy phytoestrogens in prostate cancer.

Holzbeierlein JM, McIntosh J, Thrasher JB.

Curr Opin Urol. 2005 Jan;15(1):17-22. Review.

PMID:
15586024
20.

Supplemental Content

Support Center